FDA Import Refusal AEK-2128371-7/10003/1 — ACCENT PHARMA
The FDA refused shipment AEK-2128371-7/10003/1 from ACCENT PHARMA (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Sep 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY26 METFORMIN (ANTI-DIABETIC)
- Charges
- 75